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Abstract . The interferons are cytokines with antiviral,
cell growth regulatory, and immunomodulatory activi-
ties . These activities are mediated by the proteins in-
duced by the interferons. Earlier we described a gene
cluster (the 200 cluster) consisting of at least six ad-
jacent, interferon-activatable genes located next to
the erythroid alpha-spectrin locus on murine chromo-
some 1 . The genes of the cluster arose by repeated
gene duplication and they specify proteins with pro-
nounced sequence similarity. We have now raised poly-
clonal antibodies against a segment from one of these
proteins (the 204 protein of 72 kD) . Using these, we
established that the 204 protein is a phosphoprotein
whose level in cells from various murine lines can be
increased up to 75-fold upon treatment with alpha in-
HE interferons (IFNs)' are a family of cytokines with
antiviral, cell growth regulatory, and immunomodula-
torY activities (LengYel, 1982 ; Pestka et al ., 1987; De
Maeyer and De Maeyer-Guignard, 1988) . There are three
classes ofIFNs : alpha (inhumans-at least 15 species), beta
(inhumans-one species), andgamma (inhumans-one spe-
cies) . The binding of IFNs to specific cell surface receptors
on cells from vertebrates induces the synthesis of a large va-
riety of proteins . The alpha and beta IFNs on the one hand
and gamma IFN on the other hand induce distinct but over-
lapping sets ofproteins . The induction appears to be primar-
ily the consequence of an enhanced rate of transcription of
particular genes . The inducible proteins appear to mediate
various activities of the IFNs . Thus, e.g ., particular induci-
ble proteins from theMx family impair the replication of the
influenza and vesicular stomatitis viruses (Staeheli et al .,
1986 ; Pavlovic and Staebeli,1991), an inducible (2'-5') oligo-
adenylate synthetase isoenzyme blocks the replication of
mengo and encephalomyocarditis viruses (Chebath et al .,
1987 ; Rysiecki et al ., 1989), the inducible indolamine 2,3 di-
oxygenase inhibits the multiplication of the protozoon Toxo-
plasma gondii (Pfefferkorn, 1984) and inducible major histo-
1 . Abbreviation used in this paper : IFN, interferon .
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terferon . Experiments involving fractionation of cell
lysates and indirect immunofluorescence microscopy of
control and interferon-treated cells revealed that the
204 protein is nucleolar and nucleoplasmic . This con-
clusion was confirmed by co-localization with B23, a
known nucleolar protein . The 204 protein is the first
interferon-induced protein found to be located in the
nucleoli, the subcellular organelles of ribosomal RNA
production and ribosome assembly. It remains to be
seen whether the 204 protein affects any of these pro-
cesses . Studies on 204 protein function should be facil-
itated by the availability of complete cDNA clones and
the finding of cell lines in which the expression of this
protein is impaired .
compatibility complex proteins are involved in the functioning
oftheimmune system in various ways (Srivastava et al ., 1991) .
The subcellular locations of several IFN-induced proteins
have been determined . Some proteins from the Mx family
were localized in the nucleus and others in the cytoplasm
(Pavlovic and Staeheli, 1991) . Some isoenzymes from the
(2'-5') oligoadenylate synthetase family were localized in the
nucleus ; others in the cytoplasm or associated with mem-
branes (St . Laurent et al ., 1983 ; Chebath et al., 1987) . In
the case ofsome IFN-induced proteins with antiviral activ-
ity, the proteins may be located at the sites of replication of
the viruses they control (Staeheli, 1990 ; Pavlovic and Stae-
heli, 1991) .
We established earlier the cDNA sequence encoding an
IFN-inducible 72-kD murine protein (the 204 protein)
(Choubey et al ., 1989) . This protein includes two apparently
contiguous, -200-amino acid-long segments with much
(34 %) sequence similarity, as well as a region including four
perfect and three imperfect repeats of a seven-amino
acid-long segment . The 204 protein is encoded by the Ifi
204 gene which is part ofacluster (the 200 cluster) ofat least
six IFN-inducible murine genes (Opdenakker et al ., 1989 ;
Kingsmore et al ., 1989) . The cluster was mapped to murine
chromosome 1, between the erythroid alpha-spectrin and the
amyloid P-component loci . The mRNAs specified by the
1333genes from the cluster share much sequence similarity and
the cluster appears to have evolved by repeated gene duplica-
tion (Choubey et al., 1989) . The functions of the proteins
specified by the gene cluster remain to be established.
Here, we report the first step towards this goal-the prepa-
ration and use of a polyclonal antiserum which specifically
recognizes the 204 protein. Our studies reveal that the 204
protein is IFN inducible and is phosphorylated. Its IFN-
induced level is different in different inbred strains of mice.
Moreover, the 204 protein is located in the nucleolus and
nucleoplasm of interphase murine cells.
Materials and Methods
Reagents
Recombinant human IFN alpha 2/alpha 1-83 (sp act 8.1 x 10' U/mg) was
a generous gift from H. Weber and C. Weissmann (University of Zurich,
Zurich, Switzerland). This human IFN was shown to be highly active in
murine cells (Weber et al., 1987) .
Cell Lines and Growth Conditions
Mouse AKR 2B (obtained from H. Moses, Vanderbilt University, Nash-
ville, TN; Getz et al., 1976), BALB/c 3T3 (clone A31) (ÁTCC CCL 163;
obtained from C. Stiles, Dana Farber Cancer Institute, Boston, MA), BLK
SV HD.2 A.5R.1 VA.3R.1 (BLKS) (ACC TIB 88), and L929 (ATCC CCL
1) cells were grown in monolayers in DME medium (Gibco Laboratories,
Grand Island, NY) supplemented with 10% FBS. NIH 3T3 (obtained from
R. Weinberg, The Whitehead Institute, Cambridge, MA) (ATCC CRL 1658)
and Ehrlich ascites tumor cells (obtained from E. Henshaw, University of
Rochester, Rochester, NY) were grown in DME medium, supplemented
with 5% calf serum. The cells were passaged when reaching semi-
confluency (40-60% confluency). If so indicated, IFN was added (unless
otherwise stated, to semiconfluent cultures and at 1,000 U/ml) for24 h. For
labeling with [35S]methionine, cells were grown in methionine minus
DME medium, supplemented with 5% dialyzed calf serum in the presence
of IFN for 1 h. Thereafter, the same medium was supplemented with
[35S]methionine (200 pCi/ml) (sp act 1,000 Ci/mmole; Amersham Corp.,
Arlington Heights, IL) together with IFN and the incubation was continued
for three more hours. For 32plabeling, the cells were grown in DME
medium inthe presence of IFN for 10 h and subsequently in phosphate-free
DME medium (Gibco Laboratories) supplemented with 32P-orthophos-
phate (100 ACi/ml; Amersham Corp., Arlington Heights, IL) in the pres-
ence of IFN, overnight. The control cultures were not treated with IFN.
Preparation ofa 204fusion Protein
A polyclonal antiserum was raised in a rabbit against the NH2-terminal
segment ofthe 204 protein: the cDNA fragment from nucleotide 89 to 742
(see Fig. 2 in Choubey et al., 1989), (BalI-BanII fragment) coding for this
polypeptide was blunt end ligated in the SmaI site of the pGEX-1 Esche-
richia coli expression vector (Amrad Corporation, Kew, Victoria, Austra-
lia) to regenerate the proper reading frame. The 5' cloning site of the 204
cDNA insert was confirmed by sequencing. The glutathione transferase-
204 fusion protein was expressed in E. coli XL-1 blue and was affinity
purified on glutathione-agarose beads (Sigma Chemical Company, St.
Louis, MO) according to the method of Smith et al. (1988) .
Preparation and Immunoaffinity Purification of
Antibodies to the 204fusion Protein
The affinity purified fusion protein preparation was subjected to SDS-PAGE
at the preparative scale and the major Coomassie blue-stainable band was
cut out and used for immunization of a rabbit at the Pocono Rabbit Farm
and Laboratory (Dutch Hill Road, Canadensis, PA) according to their pro-
cedure. The antibodies to the 204 protein were immunoaf&nity purified by
passing the antiserum through a column in which the antigen had been cou-
pled to tresyl-activated agarose (American Bioanalytical, Schleicher and
Schuell, Keene, NH) as suggested by the supplier. The antibodies eluted
from the column at alkaline pH (11.5) were immediately neutralized and
were stored at -20°C.
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SubcellularLocalization of
the 204 Protein: Fractionation ofLysatesfrom
AKR 2B Cells
(See Fig. 5) The procedure of Yung et al . (1985) was followed for lysing
the cells in a hypotonic buffer, fractionating the lysate into a cytoplasmic
and nuclear fraction and subfractionating the nuclear fraction into
nucleoplasmic and nucleolar subfractions. The nuclear and nucleolar
pellets were extracted with RIPA buffer and 50-lig protein aliquots from
these two extracts and from the cytoplasmic and nucleoplasmic fractions
were assayed for protein 204 content by inununoblotting with the anti-204
antiserum.
Assay ofthe Binding ofthe 204 Protein
in Isolated Nuclei: Treatment with Various
Concentrations ofNaCl
The lysatefromIFN-treatedAKR2B cells was prepared and the nuclei were
isolated from the lysate according to the procedure ofOhtsuboet al. (1989).
The nuclei were incubated with NaCl at the concentration indicated in 10
mM Hepes (pH 7.5), 5 mM KCI, and 2 MM M9C12. Thereafter, the reac-
tion mixtures were centrifuged at 1,000 g for 5 min and equal aliquots from
the supernatant fractions (extract) and the pellet fractions (residual nuclei)
were boiled in Laemmli's sample buffer (Laemmli, 1970) before assaying
for 204 protein by immunoblotting.
Immunoprecipitation and Immunoblotting
Unless otherwise indicated, cells were lysed in RIPA buffer (150mM NaCl,
1 % NP-40, 0.5% deoxycholate, 0.1% SDS, and 50 mM Tris (pH 8.0) sup-
plemented with 1 mM PMSF and 50 gg/ml leupeptin), briefly sonicated and
the cell debris was pelleted. The supernatant fractionwas collected and used
for protein estimation with the Bio-Rod kit (Bio-Rod Laboratories, Cam-
bridge, MA). Immunoprecipitations were performed using the appropriate
dilutions of the preimmune serum or of the anti-204 antiserum (1,000-
1,200-fold dilution) or of the immuno-affinity-purified anti-204 antibodies
(50-fold dilution) in RIPA buffer at4°C overnight. The precipitate was incu-
bated with protein A-Sepharose beads (Sigma Chemical Co.), 30-50,ul in
a 50% suspension in RIPA bufferat 4°C for 90 min, collectedby centrifuga-
tion, and washed with RIPA buffer, three to five times. Finally, the beads
were boiled in the sample loading buffer of Laemtnli (1970) for 4-6 min
and pelleted by centrifugation. The supernatant fractions were subjected to
SDS-PAGE. The gel was soaked in an enhancer (ResolutionTM; E. M.
Corporation, Chestnut Hill, MA) and processed for fluorography. For im-
munoblotting, the proteins were transferred from the polyacrylamide gels
to Immobilon-P (Millipore Corporation, Bedford, MA) as described (Har-
low et al., 1988) and were visualized by staining with a protein stain pon-
ceau S (Sigma Chemical Co.). After blocking with 5% nonfat dry milk in
TBS (50 mM [Tris, pH 7.5], 300 mM NaCl) the blot was immunostained
withthe anti-204 antibodies (diluted 1,200-fold) at 4°C overnight. The anti-
bodies were detected using affinity purified 1251-protein A (30 mCi/mg)
(Amersham Corp.), and autoradiography. Unless otherwise indicated, the
unpurified anti 204-antiserum was used for immunoprecipitations and
immunoblotting.
Indirect Immunofluorescence Microscopy
This was performed on IFN-treated and control AKR 2B cells that were
grown on cover slips, washed with PBS (pH 7.2), fixed with freshly diluted
2% formaldehyde in PBS atroomtemperature for 20 minand permeabilized
with (-20°C) methanol at room temperature for 4 min or with 0.1% Triton
X-100 in PBS at room temperature for 5 min. Afterblocking with 30% FBS
in PBS at 37°C for 1 h, the cover slips were incubated with pre-immune
serum (diluted500-fold) or immunoaffinity purified 204 antibodies (diluted
eightfold) or anti-B23 mAbs (diluted 30-fold) in 3% BSA in PBS at 4°C
for 2 h. The cover slips were then washed three times for 5 min each time
with PBS.
For staining ofthe 204 protein the cells were incubated with secondary,
fluoresceine-labeled sheep, anti-rabbit IgG antibodies (Cappel Laborato-
ries, Durham, NC) at the appropriate dilution in 3% BSA in PBS at 37°C
for 30 min. For staining of the B23 protein, the cells were incubated with
secondary, rhodamine-labeled goat anti-mouse IgG antibodies (Sigma
Chemical Co.) at a 30-fold dilution in PBS at 37°C for 30 min. In the case
of double immunofluorescence experiments, the two primary antibodies
(i.e., the anti-204 and the anti-B23 antibody) were incubated together as
1334was the pair ofsecondary antibodies . The cells were mounted in 3% propyl
gallate in 70% glycerol and viewed under the microscope .
In Intro Transcription and Translation
The204-cDNA insert in pBluescript (Stratagene, La Jolla, CA) was tran-
scribed using T7RNA polymerase, and themRNA obtained was translated
in a rabbit reticulocyte lysate supplemented with [35S]methionine as de-
scribed by Choubey et al . (1989) .
Partial Proteolysis
(Fig. 1 c) . The204 protein labeled with [355]methionine, was immunopre-
cipitated from IFN-treatedAKR2B cells and subjected to SDS-PAGE, to-
gether with the 204 protein translated in vitro. The gel was dried without
fixation of the proteins and autoradiography was performed . A slice from
the gel with the 204 protein band was cut out from the dried gel, inserted
into a second SDS-polyacrylamide gel, subjected to limited digestion with
S . aureus V8 protease (Boehringer-Mannheim Biochemicals, Indianapolis,
IN) andSDS-PAGE was performed as described by Cleveland et al . (1983) .
Results
The Anti-204 Antiserum Specifically Recognizes
anIFN-induced Murine Protein whose Mobility and
PeptideMapAre Indistinguishablefrom Those of
an In Yttro-translated 204 Protein
A polyclonal antiserum was generated in a rabbit injected
with a fusion protein, including a 204 protein segment of
over two hundred amino acids . The unpurified antiserum
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was immunoaffinity purified by binding to and elution from
the insolubilized fusion protein . Theantiserumturned out to
be suitable for both immunoblotting (Fig . 1 a) andimmuno-
precipitation (Fig . 1 b) . In immunoblotting, the unpurified
antiserum recognized in a total cell extract from AKR 2B
cells a 72-kD protein (Fig . 1 a, lanes 1 and 2) which was
not recognized by the preimmune serum (lanes 3 and 4) .
Treatment of a semiconfluent culture of cells with IFN for
24 h increasedthe level of the 72-kD protein >50-fold (Fig .
1 a, compare lanes1 and2) . In thecase ofimmunoprecipita-
tion, the anti-204 antiserum (Fig . 1 b, lane 4) and also the
immunoafßnity purified anti-204 antibodies (lane 6) precipi-
tatedan IFN-induced 72-kD proteinwhich was not precipi-
tatedby the pre-immune serum (Fig . 1 b, lane 2) . The level
ofthe 72ÁD protein was greatly increasedby the IFN treat-
ment (Fig . 1 b, compare lanes 4to3 and6to 5) . The mobil-
ity of the 72-kD protein was indistinguishable from that of
a 204 protein translated in vitro (the band with the lowest
mobility in Fig . 1 b, lane IVT) . (It should be noted that in
the lane IVT, the band with the lowest mobility corresponds
to the 204 protein whose translation started at the 5' prox-
imal AUG initiator codon of the 204 mRNA . The heavier
band with the next lowest mobility results from starting the
translation of themRNA at the second AUG codon from the
5' terminus) (Choubey et al ., 1989) . The apparent co-
migration of the in vivo-synthesized 204 protein with the in
vitro-translated 204protein indicates that theprotein in vivo
does not undergo posttranslational processing resulting in a
Figure 1 . Identification of the IFN-inducible 204 protein using the anti-204 polyclonal antiserum . (a) Immunoblotting . Total cell extracts
(100,ug protein per lane) from control (lanes 1 and3) or IFN-treated (lanes2and 4)AKR 2B cell cultures were fractionated by SDS-PAGE
and transferred to Inunobilon-P membranes . These were immunostained with the anti-204 antiserum (lanes 1 and 2) or the preimmune
serum (lanes 3 and 4), and 1251 protein A followed by autoradiography. The 1°C-labeled molecular size markers used (in lane M) were
phosphorylase B, 92.5 kD, BSA69 kD, and ovalburnin 46kD (AmershamCorp., Arlington Heights, IL) . The204 protein band is indicated
by an arrow. (b) Immunoprecipitation of [355]methionine-labeled protein. Total cell extracts from [355]methionine-labeled control (lanes
1, 3, and S) or IFN-treated AKR 2B cells (lanes 2, 4, and 6) were immunoprecipitated with the preimmune serum (lanes 1 and 2), the
anti-204 antiserum (lanes 3and4) or immunoaffinity purified, anti-204 antibodies (lanes Sand6) . Theimmunoprecipitates were subjected
to SDS-PAGE and visualized by fluorography. [355]methionine-labeled 204 protein was prepared by translating an in vitro-synthesized
204 transcript in a rabbit reticulocyte lysate and was analyzed by SDS-PAGE and fluorography (lane IVT) . The molecular size markers
used (in lane M) were, as in a, except that carbonic anhydrase30 kD was also included . The 204 protein band is indicated by an arrow.
(c) Limited proteolysis of the 204 protein . Aliquots of the [355]methionine-labeled 204 protein, immunoprecipitated from IFN-treated
AKR 2B cells (lane 1) or translated in vitro (lane 2), were subjected to limited proteolysis withS . aureus V8 protease in SDS-polyacryla-
mide gels and the digests were analyzed by SDS-PAGE . For further details, see Materials and Methods .Figure 2. Time course of the induction of the 204 protein by alpha
IFN in culturedAKR 2B cells . Semiconfluent cultures were treated
with IFN for the time (in hours) indicated . Total extracts (100 wg
protein per lane) prepared from the cultures were fractionated by
SDS-PAGEand analyzedby immunoblotting with the anti-204 anti-
serum . For further details see Materials and Methods.
change in mobility detectable by SDS-PAGE as used . The
identity of the in vivo-synthesized and in vitro-translated
204 proteins was further supported by the outcome of pep-
tide mapping : [IIS]methionine-labeled 204 protein was syn-
thesized in vivo and immunoprecipitated . The immunopre-
cipitate was purified by SDS-PAGE and subjected to partial
digestion withS. aureus V8 protease, together with ["S]me-
thionine-labeled204 protein translated in vitro . The peptides
generated from the two proteins revealed identical patterns of
mobility onSDS-PAGE (compare lanes 1 and 2 in Fig . 1 c) .
77me Course oftheInductionofthe204Protein by
IFNinAKR 2B Cells
The level of 204 protein in AKR 2B cells not treated with
IFN was low but detectable by immunoblotting (Fig . 2) . Ex-
posure of a semiconfluent culture to IFN resulted in a pro-
nounced increase in this level after 6 h . After a 24-h ex-
posure, the increase rose to -50-fold and after 48 h to about
75-fold (Fig . 2) .
The half-life of the 204 protein was >9 h (as determined
in cells which had been exposed to IFN for 24 h before the
addition of the protein synthesis inhibitor cycloheximide ; 50
pg/ml ; Sigma Chemical Co.) (not shown) .
The204Protein CanBe Phosphorylated In Vivo
The inspection of the amino acid sequence of the 204 protein
(Choubey et al., 1989) revealed the occurrence of potential
sites for phosphorylation by various protein kinases (Kemp
and Pearson, 1990) . This prompted us to test whether the
204 protein was phosphorylated in vivo . For this purpose,
control and IFN-treated cultures of AKR 2B cells were la-
beled by incubation with 32P-orthophosphate and aliquots
containing equal numbers of 32P cpm . were immunoprecipi-
tated with the anti-204 antiserum and subjected to SDS-
PAGE and autoradiography. The presence of 32P-labeling in
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Figure 3 . The 204 protein is
phosphorylated . Immunopre-
cipitation of 32P-labeled 204
protein from control and IFN-
treated AKR 2B cells . Total
cell extract (100 12g protein
per lane with equal numbers
of 32Pcpm) from a 32P-labeled
control culture (lane 1) and a
32plabeled culture treated with
IFN (lane2) were immunopre-
cipitated with the anti-204 an-
tiserum and subjected to SDS-
PAGE and autoradiography.
Horizontal lines indicate the
bands corresponding to '°C-la-
beled molecular size markers
(in order of increasing mobil-
ity : BSA 68 kD, ovalbumin 46
kD, and carbonic anhydrase
30 kD) . The 204 protein band
is indicated by an arrow. For
further details see Materials
and Methods .
the immunoprecipitated 72-kD protein in IFN-treated cells
indicated that the 204 protein was phosphorylated in IFN-
treated cells (in Fig. 3) . No phosphorylation of 204 protein
was detected in control cells . However, this undetectability
might be the consequence ofthe very low level of204 protein
in control cells (only 1/50 of that in IFN-treated cells) . Thus
our results are no basis for conclusions concerning the phos-
phorylation of the 204 protein in control cells .
Differences in theInducibility ofthe204Protein by
IFNin Cell Lines Derivedfrom VariousInbred Strains
ofMice
Studies withmRNAs from various inbred strains ofmice and
from cell lines derived from the strains uncovered differ-
ences in the inducibility of the mRNAs from the gene 200
cluster (Toniato, E ., and P . Lengyel, unpublished data ;
Gariglio et al ., 1992) . Immunoblotting involving the use
of the anti-204 antiserum also revealed such differences
among murine cell lines. Thus, the 204 protein was induc-
ible by IFN in cultures of BALB/c 3T3 (Fig. 4, lanes 5
and 6), NIH 3T3, L929, and EAT cells (not shown) to a
similar extent as in cultures of AKR2B cells (Fig . 4, lanes
1 and 2) . However, in BLKS cells (a line derived from
the C57 BL/6 inbred strain of mice), the constitutive level
of the 204 protein was not detectable and IFN treatment in-
creased the level only to that present in control AKR 2B
cells .
The BLKS cell line in which the inducibility of the 204
protein by IFN is so much poorer than in many other cell
lines might be of use in future studies on the function of the
204 protein .
Subcellular Localization of the204Protein:
Fractionation ofLysatesfromAKR2B Cells
To determine the subcellular location ofthe 204 protein, cul-
tures of control and IFN-treated AKR 2B cells were lysed,
the lysate was fractionated, and the fractions obtained wereFigure 4 . Differences in the inducibility of the 204 protein by IFN
in fibroblast lines derived from various inbred strains of mice. Total
cell extracts (100 Fjg protein per lane) from control cultures (lanes
1, 3, and 5) orcultures exposed to 1,000 U/ml ofIFNfor24 h (lanes
2, 4, and 6) from AKR 213 cells (AKR ; lanes 1 and 2) BLKS cells
(BLK ; lanes 3 and 4) and BALB/c 3T3 cells (ALB/c ; lanes 5 and
6) were fractionated by SDS-PAGE and analyzed by immunoblot-
ting with the anti-204 antiserum . For further details see Materials
and Methods .
assayed for 204 protein by SDS-PAGE and immunoblotting.
The patterns in Fig . 5 reveal that in the case of IFN-treated
cells, the bulk of 204 protein (>98%) was nuclear (Fig . 5,
lane 6), only<2% was cytoplasmic (Fig . 5, lane 5) . Further-
more, within the nuclear fraction, 40% of the 204 protein
was nucleolar (Fig . 5, lane 8) and 60% nucleoplasmic (Fig.
5, lanes 7) . In the case of the lysate from control cells, little
204 protein was detectable in this experiment (Fig . 5, lanes
1-4) .
NucleolarandNucleoplasmic Localization ofthe
204 Protein: Indirect Immunoiluorescence Microscopy
ofControland IFN-treatedAKR 2B Cells Stained
with Anti-204AntibodiesandAnti-B23 Antibodies:
Effect ofActinomycinD Treatment
For immunofluorescence microscopy theAKR2B cells were
grown, treated with IFN (if so indicated) on cover slips,
fixed, permeabilized, stained with preimmune serum or im-
munoaffinity purified rabbit anti-204 antibodies, and visual-
ized with fluoresceine-labeled sheep anti-rabbit IgG. The
use ofpreimmune serum resulted in no detectable staining
of cells (not shown) . The photomicrographs in Fig. 6, a and
b reveal that the immunoaffinity purified anti-204 antibodies
gave rise to a very faint staining ofthe nuclei in control cells
and a bright staining of the nuclei in IFN-treated cells. The
cytoplasm was very poorly stained, even in the case ofIFN-
treated cells .
The pattern of nuclear staining in both IFN-treated and
control cells was punctate and characteristic of interphase
nucleoli in these cells . In cells treated with IFN, the
nucleoplasm was also stained (although much less brightly
than the nucleoli) . Furthermore, the brightness of nuclei in
different IFN-treated cells was not quite uniform .
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Figure 5 . Subcellular localization of the 204 protein : fractionation
of lysates fromAKR 2B cells . Extracts from control (lanes 1 to 4)
or IFN-treated cells (lanes 5 to 8) were fractionated into cytoplas-
mic (lanes 1 and 5) and nuclear fractions (lanes 2 and 6) . The nu-
clear fraction was further subfractionated into nucleoplasmic (lanes
3 and 7) and nucleolar fractions (lanes 4 and 8) . Aliquots (contain-
ing 50 -pg protein from each fraction) were tested for 204 protein
by immunoblotting with the anti-204 antiserum . The 204 protein
band is indicated by an arrow . For further details see Materials and
Methods .
To verify the nucleolar localization of the 204 protein a
mAb against the nucleolar B23 protein (Lischwe et al .,
1979 ; Yung et al ., 1990) was used . After fixation and per-
meabilization of IFN-treated cells, they were first stained
with both the immunoaffinity purified anti-204 antibodies
and the monoclonal anti-B23 antibodies and the two antibod-
ies were visualized (in the case of the anti-204 antibodies
with fluoresceine-labeled anti-rabbit IgG antibodies and, in
the case of anti-B23 antibodies, with rhodamine-labeled
anti-mouse IgG antibodies) . The patterns in Fig . 7 reveal
that the 204 protein is located in the same subcellular or-
ganelles (a) as the nucleolar B23 protein (b) . This co-
localization ofthe 204 protein with the nucleolar B23 protein
clearly indicates that much of the 204 protein is located in
the nucleoli in interphase AKR 2B cells .
As a further test of the localization of the 204 protein, we
tested the effect of actinomycin D treatment of cells on the
immunofluorescence staining pattern . Actinomycin D, an
agent intercalating into DNA, is a potent inhibitor of tran-
scription and electron microscopic studies revealed that the
exposure of cells to this agent results, among other changes,
in nucleolar segregation, i.e ., the dispersion ofsome nucleo-
lar components (Busch and Smetana, 1970) .
In line with the nucleolar localization of the 204 protein,
we found that the exposure of IFN-treated cells to actinomy-
cin D (1 p,glml for 1 h) changed the immunofluorescence pat-
tern of the 204 protein from punctate and characteristic of
nucleoli to amore dispersed, nucleoplasmic pattern (Fig . 8,
a and b) .
Characteristics oftheBinding of the204Protein in
Isolated Nuclei
Nuclei (isolated from IFN-treated AKR 2B cells) were in-
cubated with increasing concentrations of NaCl and the
1337Figure 6. Nuclear localization ofthe204 protein : indirect immunofluorescence microscopy ofcontrol andIFN-treatedAKR2B cells stained
with anti-204 antibodies . Control (a) and IFN-treated AKR 2B cells (b) were fixed, permeabilized, stained with immunoaffinity purified
and-204 antibodies, and the anti-204 antibodies were visualized with fluoresceine-labeled secondary antibodies . For further details see
Materials and Methods . Bar, 10 ),m .
Figure 7 . Co-localization of the204 protein with the nucleolarB23 protein: indirect immunofluorescence microscopy of IFN-treatedAKR
2B cells stained with anti-204 antibodies and and-B23 antibodies . IFN-treatedAKR2B cells were fixed, permeabilized, and stained with
immunoaffinity-purified anti-204 antibodies (a)andmonoclonal anti-B23 antibodies (b) . The anti-204 antibodies were visualized with fluo-
resceine-labeled secondary antibodies andthe anti-B23 antibodies were visualized with rhodamine-labeled secondary antibodies . For fur-
ther details see Materials and Methods. Bar, 10 jm.
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1338Figure 8. Indirect immunofluorescence microscopy of IFN-treated AKR 2B cells stained with anti-204 antibodies : effect of actinomycin
D treatment on the distribution of the 204 protein . IFN-treated AKR 2B cells without (a) or after treatment with actinomycin D (1 jug/ml ;
Sigma Chemical Co .) for 1 h (b) were fixed, permeabilized, and stained with immunoaffinity purified anti-204 antibodies and the antibodies
were visualized with fluoresceine-labeled secondary antibodies . For further details see Materials and Methods . Bar, 10 Am .
amounts of 204 protein solubilized as well as the amounts
retained in the residual nuclear fractions after the incuba-
tions were determined by SDS-PAGE and immunoblotting .
Most of the 204 protein was released by 0.2 M NaCI (not
shown) . Treatment with DNase 1, (resulting in the degrada-
tion of the bulk of the chromosomal DNA into fragments of
2 kb or smaller ; not shown) or treatment with RNase A (at
concentrations up to 1.5 mg/ml ; not shown), however, did
not result in the release ofdetectable amounts of204 protein .
Discussion
We have generated a polyclonal rabbit antiserum against the
NH2-terminal segment of the 204 protein . In western blot-
ting and immunoprecipitation assays the antiserum specif-
ically recognized a 72-kD protein in total cell extracts from
several murine cell lines. This protein was identified as the
204 protein by (a) its co-migration in SDS-PAGE with 204
protein translated in a reticulocyte lysate driven by an in vitro
transcript of204cDNA and (b) the co-migrationofthe prod-
ucts ofpartial proteolytic digestion ofthe 72-kD protein with
those obtained from the 204 protein synthesized in vitro .
This co-migration ofthe 204 protein formed in vivo with that
synthesized in vitro makes it likely that no large groups were
attached to the protein in the course ofposttranslational pro-
cessing . However, an experiment involving immunoprecipi-
tation from an extract of IFN-treated '2P-labeled AKR 2B
cells revealed that the 204 protein is phosphorylated . The
site(s)ofphosphorylationand the phosphorylating enzyme(s)
remain to be identified . The 204 protein amino acid sequence
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contains potential sites for phosphorylationby CAMP-depen-
dent kinase, protein kinase C, protein-tyrosine kinase, as
well as casein-kinase II (Kemp and Pearson, 1990) . Several
nucleolar phosphoproteins are known to have phosphoryla-
tion sites for casein-kinase II (Olson, 1990) .
The basal level of 204 protein in growing AKR 2B cells
was low and exposure to IFN resulted in an increase in this
level : this was detectable after a 6-h exposure, N50-fold after
24 h and -75-fold after 48 h .
We have reported earlier that (a) treatment with IFN in-
creases the level of several mRNAs specified by genes from
the 200 cluster (e.g ., 202 mRNA, 203 rnRNA) (Engel et al .,
1988) and (b) as demonstrated in the case of the 202 gene,
this increase in mRNA level is in consequence of an in-
creased rate of transcription (Engel et al ., 1985) . Experi-
ments involving northern blotting (not shown) established
that the treatment ofAKR 2B cells with IFN strongly en-
hanced the level of 204mRNA, with similar kinetics as that
of 202 mRNA . This finding is in line with the remarkable
sequence similarity of the 5' flanking regions of the202 and
204 genes (97% in an -0.7-kb-long segment) (Choubey et
al ., 1989) . These results make it likely that the treatment
with IFN increased the level of the 204 protein primarily by
increasing the level of 204 mRNA .
A comparison ofextracts from several IFN-treated murine
cell lines revealed similarly high inducibilities of the 204
protein byIFN in all, except one line-BLKS . In control cul-
tures from this line, the 204 protein was barely detectable
and treatment with IFN increased the level only to that in
control AKR 2B cells . The molecular basis of this impair-
1339ment remains to be established. It is relevant, however, that
in the BLKS cell line (in which the IFN inducibility of some
mRNAs is unimpaired) the 202 protein (Choubey and Len-
gyel, manuscript in preparation) and 202 mRNA (which are
similar in sequence to the 204 protein and the 204 mRNA)
remain undetectable even after treating the cells with IFN
(Toniato, Choubey, and Lengyel ; unpublished data). More-
over, the defect in 202 gene expression is manifestedalso in
the inbred strain of mice (C57 BL/6) from which the BLKS
cell line originated. The mechanism of this impairment of
202 gene expression has been explored elsewhere (Gariglio
et al., 1992) . Two
approacheswere followed for determining the subcel-
lular location of the 204 protein: (a) fractionation of AKR
2B cell lysates, coupled with immunoblotting, and (b) in-
direct immunofluorescence microscopy. Both approaches in-
dicated that the large majority of the protein was distributed
between the nucleoli and the nucleoplasm . Co-localization
of the 204 protein with B23, a known nucleolar protein
(Lischwe et al., 1979), supported this nucleolar assignment.
As revealed by SDS-PAGE analysis (not shown), the 204
protein is a minor component of nucleolar proteins even in
cellstreated with IFN. Itwas not detected by Coomassie blue
staining, perhaps in consequence of masking by major
nucleolar proteins.
The N112-terminal region of the 204 protein has several
short sequences rich in basic amino acid residues: e.g., -Lys-
Lys-Ser-Lys-Ala-Ala-Lys- and -Lys-Lys-Glu-Arg-. Similar
sequences have been shown to serve as nuclear targeting sig-
nals in otherproteins. (Nigget al., 1991; Silver, 1991). Seven
amino acids and 39 amino acids in the COOH-terminal
direction from the -Lys-Lys-Glu-Arg- sequence the 204 pro-
tein contains putative casein kinase II phosphorylation sites
(-Thr-Ser-Leu-Glu- and Thr-Gln-Glu-Glu-, respectively).
Such sites flanking nuclear targeting signals were proposed
to increase the rate of transport of proteins into the nucleus
(Rihs et al., 1991).
The incubation of nuclei isolated from IFN-treated cells
with 0.2 M NaCl released the 204 protein indicating that it
is nota componentofthe nuclear scaffold. DNaseI treatment
(resulting in the cleavage ofDNA into segments shorter than
2 kb), however, did not release detectable quantities of the
protein suggesting that it is not associated with DNA. Simi-
larly, treatment with RNase A (at a concentration as high as
1.5 mg protein/ml) did not release 204protein either, making
it probable that this protein resides in a nuclease-resistant
compartment. RNase A treatment was shown to release
some other nucleolar proteins (e.g., significant amounts of
nucleoline (Olson and Thompson, 1983) and small amounts
offibrillarin) (Ochs et al., 1985). The 204 protein resembles
a few of the major nucleolar proteins in lacking acidic or
glycine-rich segments and known RNA-recognition motifs
(Olson, 1990).
Incubation of IFN-treated cells with actinomycin D
changed the immunofluorescence pattern of the 204 protein
from a nucleolar and punctate version into a more dispersed
nucleoplasmic version. This reveals that the protein is as-
sociated with components ofthe nucleoli which become dis-
integrated after actinomycin D treatment. The treatment was
found earlier to result in the translocation of the HeLa B23
protein from the nucleoli to the nucleoplasm (Yung et al. ,
1985, 1990) without affecting the nucleolar location of some
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other proteins, e.g., C23 and fibrillarin (Chan et al ., 1985) .
Actinomycin D is knownto inhibit RNA synthesis, the mech-
anism by which it induces the translocation ofnucleolar pro-
teins into the nucleoplasm however remains to be explored.
Though the large majority ofthe 204 protein was localized
in nuclei, it remains to be examined whether the protein
shuttles between the nucleus and the cytoplasm. Some major
nucleolar proteins (e.g., nucleolan and B23) were shown to
shuttle (Borer et al., 1989; see also Meier and Blobel, 1990) .
The gene specifying the 204 protein is partofthe 200 clus-
ter of at least six, IFN-activatable genes encoding proteins
with very pronounced sequence similarity (Opdenakker et
al., 1989; Choubey et al., 1989). The subcellular locations
of the proteins other than 204 specified by the 200 cluster
remain to be established . It may be relevant to note that the
four similar proteins ([2'-51 oligoadenylate synthetases)
specified by another IFN-activatable gene family, were
shown to reside in different subcellular compartments (Che-
bath et al., 1987).
The 204 protein is the first among the IFN-induced pro-
teins to be localized in the nucleolus. The various activities
ofIFNs (e.g., antiviral, immunomodulatory, and cell growth
regulatory) are mediated by the various proteins the IFNs in-
duce. The biological roles of the 204 protein in control and
in IFN-treated cells remain to be established. Its nucleolar
location makes it possible that it is affecting steps in the bio-
genesis of ribosomes (Scheer and Benavente, 1990; Reeder,
1990) but antiviral and/or cell growth regulatory activities
are also conceivable.
We have transfected into murine cells a 204 cDNA expres-
sion construct driven by a strong enhancer. The constitutive
overexpression of the 204 protein appeared to impair cell
proliferation .
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